Recognizing that talent is the core of biotechnology development, Diamond Biofund established the “Taiwan Bio-Development Foundation” after its founding. Over the past twelve years, Diamond Biofund has unconditionally supported chair professors in cultivating outstanding talent in Taiwan’s biomedical field, donating NT$1 billion to establish the foundation and NT$20 million annually. To date, Diamond Biofund has donated NT$25 million to each of 18 outstanding chair professors from Academia Sinica, the National Health Research Institutes, and various universities, who have collectively trained 160 Ph.D. students, 270 master’s students, and over 100 postdoctoral researchers.
In addition, the “Taiwan Bio-Development Foundation” launched Taiwan’s highest medical award, the “Wu Ho-Su TBF Medical Award,” to encourage outstanding medical researchers under the age of 50 in Taiwan to pursue innovative research, with a prize of NT$2.1 million for each recipient, fostering talent for the long-term development of the biomedical industry.
The “Taiwan Bio-development Foundation” was founded by Diamond Biofund to cultivate biomedical talent in Taiwan. Each year, it selects and supports outstanding scholars and professors in the biomedical field through the “TBF Chair in Biotechnology” and the “Wu Ho-Su TBF Medical Award.” Through presentations and student poster competitions, the foundation fosters technical exchange and knowledge sharing, with the aim of nurturing more talent in the biomedical field under the guidance of scholars.
In 2025, Diamond Biofund made a total contribution of NT$4.6 million in support of the“Taiwan Bio-development Foundation”, including NT$2.5 million for one TBF Chair in Biotechnology (selected in 2024) and NT$2.1 million for one Wu Ho-Su TBF Medical Award (selected in 2025).
On August 11, 2025, Diamond Biofund, together with the Taiwan Stock Exchange and the Taipei Exchange, co-hosted the “2025 Asia-Pacific Biotech Investment Forum” at the W Taipei Hotel, bringing together over 500 experts from industry, academia, and research. During the forum, one TBF Chair in Biotechnology and one Wu Ho-Su TBF Medical Award were presented. The Wu Ho-Su TBF Medical Award, funded by Diamond Biofund with NT$2.1 million, recognized a young scholar for innovative research in the biomedical field. Diamond Biofund mobilized 19 employees to participate in the forum.
On December 5, 2025, TBF held the “2025 Biotech and Medical Innovation Symposium” at the Grand Hilai Taipei, with more than 200 experts in attendance. Diamond Biofund mobilized 7 employees to participate, demonstrating its continued support for TBF。
By encouraging and supporting innovative research in biotechnology and pharmaceuticals, we seek to transform these innovations into practical applications and commercialization opportunities. We aim to build value-creation platforms and foster cross-industry collaborations, expanding the technological applications in the biotechnology field, creating future investment value.

The 2025 TBF Lecture awarded Distinguished Research Fellow Yu-Ju Chen of Academia Sinica with a NT$25 million prize.

Taiwan’s highest medical award, the Wu Ho-Su TBF Medical Award, was presented to Professor Zong-Hong Lin of NTU with a NT$2.1 million prize.
* Note: Our company’s social participation activities are not limited to our operational base (Taipei City). Instead, from a community risk perspective, we focus on the cultivation of biotechnology talent in Taiwan that faces both high risk and high potential. Through concrete actions, we aim to leverage the company’s influence to continuously support the development of Taiwan’s biotechnology and pharmaceutical industry and to fulfill our corporate social responsibility.
1.
2.
(1)
Chao Street: Participants engaged in interactive art projects, including hand-painted wooden panels and large wooden carvings inspired by local flora and DaWu Mountain.
(2)
Chao Market: Focusing on “Sustainable Coexistence,” local brands were showcased through food, crafts, and interactive experiences, revitalizing the old street market.
(3)
Chao Sound: Performances ranged from traditional puppet theater to contemporary music collaborations with community residents and students.
(4)
Chao Exhibition: Students explored local businesses, inviting participants to experience the charm of Chao-Zhou’s small shops and streets.
(5)
Chao Lecture: Lecture on art and community co-creation featured artists and scholars sharing insights on the Spring Tide Collective and local culture.

Chao Market – Experience greenery, local culture, and sustainability.

Chao Market – Re-stitch Workshop – Make exclusive souvenirs with the Kaulin Foundation.

Chao Sound – Enjoy traditional and contemporary indigenous music.

Chao Exhibition – Explore Chao-Zhou and discover its unique charm.
3.
Sustainable Pillow Workshop – Nan-Zhou Junior High students collaborated with the Kaulin Foundation and local craft teachers to create eco-friendly, commemorative pillows.
* Note: Considering that the disparity in culture and educational resources between the regions of Taiwan, as well as urban and rural areas, is one of the community risks, our company’s social participation activities are not limited to the company’s operational base (Taipei City). Instead, we extend our focus to include remote areas of Taiwan as part of our community risk consideration. The goals are to leverage the company’s influence to support social development and fulfill our corporate social responsibility.
Diamond Biofund annually collaborates with leading universities and their finance departments to organize internship programs. Each year, interns participate in a summer internship during July and August, where they gain exposure to the company’s operations and engage in processes such as investment screening and evaluation. This hands-on experience helps cultivate practical industry knowledge and skills. From mid-June to August 2025, two economics students from top universities in Taiwan participated in an internship.
Diamond Biofund serves as a director of the Taiwan Venture Capital Association and actively participates in association activities to understand the latest trends and regulatory developments in the industry while fostering positive interactions with peers.
醣基生醫股份有限公司
2017年9月27日登錄興櫃市場交易 (6586:TT)
公司所在地
台北,台灣
公司設立日期
2013
登錄公開市場
2017
公司官網
https://www.chopharma.com/cn/index.html